Diagnostics

Menarini’s cell based non-invasive prenatal technology demonstrates high resolution detection of fetal genomic abnormalities from a simple maternal blood draw

Data presented at the 2024 FMF (Fetal Medicine Foundation) World Congress in Lisbon, Portugal shows the potential for an automated system to…

5 months ago

US Equestrian Names Zomedica’s PulseVet System as the Official Shock Wave Therapy of US Equestrian Team Veterinarians

PulseVet® Shock Wave Device Supports Equine Athletes Ahead of Major International Team Events ANN ARBOR, MI / ACCESSWIRE / July…

5 months ago

Spectral AI Joins Russell Microcap® Index

DALLAS, July 01, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence…

5 months ago

Nashville-Based ObjectiveHealth, QualDerm Partners Expand Partnership to Increase Care Options for Patients

NASHVILLE, Tenn.--(BUSINESS WIRE)--#aesthetics--ObjectiveHealth, a Nashville-based integrated research and technology platform company, announced today that it is expanding its partnership with…

5 months ago

Dyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization Partnership

JUPITER, Fla., June 28, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (NASDAQ: DYAI), announced today that they have entered…

5 months ago

Roche’s Vabysmo gets CHMP recommendation for third indication retinal vein occlusion (RVO)

Positive recommendation is based on two Phase III studies. In addition to robust retinal drying with Vabysmo, these data show…

5 months ago

Orchard Therapeutics Celebrates Global Progress toward Advancing Newborn Screening for MLD on International Neonatal Screening Day

A nomination to add MLD to the U.S. Recommended Uniform Screening Panel has been submitted by a multi-disciplinary expert working…

5 months ago

CHMP recommends EU approval of Roche’s PiaSky for people with PNH, a rare, life-threatening blood condition

If approved, PiaSky will be the first monthly subcutaneous (SC) treatment for paroxysmal nocturnal haemoglobinuria (PNH) in the EU Additionally,…

5 months ago

Magnolia Medical Launches New Magnolia Analytics™ Service to Streamline Data Capture and Quantify the Clinical & Cost Effectiveness of Preventing Sepsis Misdiagnosis

This unique, proprietary service is exclusively available to Magnolia Medical customers as part of its Mission to ZERO® standards change…

5 months ago